The hepatitis C virus epidemics in key populations (including people who inject drugs, prisoners and MSM): the use of direct-acting antivirals as treatment for …
NK Martin, P Vickerman, GJ Dore… - Current opinion in HIV …, 2015 - journals.lww.com
The hepatitis C virus epidemics in key populations (includin... : Current Opinion in HIV and AIDS
The hepatitis C virus epidemics in key populations (including people who inject drugs, prisoners …
The hepatitis C virus epidemics in key populations (including people who inject drugs, prisoners …
Hepatitis C virus treatment as prevention in people who inject drugs: testing the evidence
M Hickman, D De Angelis, P Vickerman… - Current opinion in …, 2015 - journals.lww.com
Eliminating HCV through scaling up treatment is a theoretical possibility. But empirical data
are required to demonstrate that HCV treatment can reduce HCV transmission, which will …
are required to demonstrate that HCV treatment can reduce HCV transmission, which will …
Doing social network research: Network-based research design for social scientists
GL Robins - 2015 - torrossa.com
This book is principally intended for social scientists wanting to undertake social network
research. It assumes the reader already knows a thing or two (perhaps even a lot) about …
research. It assumes the reader already knows a thing or two (perhaps even a lot) about …
[PDF][PDF] The impact of injecting networks on hepatitis C transmission and treatment in people who inject drugs
M Hellard, DA Rolls, R Sacks‐Davis, G Robins… - …, 2014 - Wiley Online Library
With the development of new highly efficacious direct‐acting antiviral (DAA) treatments for
hepatitis C virus (HCV), the concept of treatment as prevention is gaining credence. To date …
hepatitis C virus (HCV), the concept of treatment as prevention is gaining credence. To date …
Hepatitis C virus treatment as prevention in an extended network of people who inject drugs in the USA: a modelling study
Background Chronic infections with hepatitis C virus (HCV) and HIV are highly prevalent in
the USA and concentrated in people who inject drugs. Treatment as prevention with highly …
the USA and concentrated in people who inject drugs. Treatment as prevention with highly …
[PDF][PDF] Hepatitis C treatment as prevention of viral transmission and liver‐related morbidity in persons who inject drugs
Hepatitis C virus (HCV) seroprevalence remains high in people who inject drug (PWID)
populations, often above 60%. Highly effective direct‐acting antiviral (DAA) regimens (90 …
populations, often above 60%. Highly effective direct‐acting antiviral (DAA) regimens (90 …
Mathematical modeling of hepatitis c virus (HCV) prevention among people who inject drugs: A review of the literature and insights for elimination strategies
AB Pitcher, A Borquez, B Skaathun… - Journal of theoretical …, 2019 - Elsevier
Abstract In 2016, the World Health Organization issued global elimination targets for
hepatitis C virus (HCV), including an 80% reduction in HCV incidence by 2030. The vast …
hepatitis C virus (HCV), including an 80% reduction in HCV incidence by 2030. The vast …
[PDF][PDF] Eradication of hepatitis C infection: the importance of targeting people who inject drugs
M Hellard, JS Doyle, R Sacks‐Davis… - …, 2014 - Wiley Online Library
Hepatitis C virus (HCV) affects 170 million people worldwide and causes significant
morbidity and mortality. 1 In high-income countries, people who inject drugs (PWID) are at …
morbidity and mortality. 1 In high-income countries, people who inject drugs (PWID) are at …
Hepatitis C virus phylogenetic clustering is associated with the social-injecting network in a cohort of people who inject drugs
It is hypothesized that social networks facilitate transmission of the hepatitis C virus (HCV).
We tested for association between HCV phylogeny and reported injecting relationships …
We tested for association between HCV phylogeny and reported injecting relationships …
Hepatitis C transmission and treatment in contact networks of people who inject drugs
Hepatitis C virus (HCV) chronically infects over 180 million people worldwide, with over
350,000 estimated deaths attributed yearly to HCV-related liver diseases. It disproportionally …
350,000 estimated deaths attributed yearly to HCV-related liver diseases. It disproportionally …